Author

L. Yerly

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

J. Abe· 1 shared P. Pfenninger· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

J. Abe

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Naive and in vitro-activated primary mouse CD8+ T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering

P. Pfenninger, L. Yerly, J. Abe

This study shows that nucleofection-based CRISPR/Cas9 editing preserves in vivo immune function of naive CD8+ T cells but slightly impairs in vitro-activated cells, with varying gene product decay rates.

bioRxiv · Sep 14, 2021Immunology